- Home
- / IO Biotech
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
IO Biotech financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.3
2024-10-29
Market Capitalization
$85.3 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|
| General and administrative expense | 11.1M | 24.4M | 23.6M | 23.7M |
| Operating expense total | 71.4M | 95.2M | ||
| EBIT | (41.2M) | (71.4M) | (91.4M) | (95.2M) |
| Investment income | 1.4M | 5.9M | 4.7M | |
| Pre tax profit | (67.8M) | (70.2M) | (85.2M) | (94.0M) |
| Income tax expense | 68.0K | 1.3M | 852.0K | 1.4M |
| Net Income | (67.9M) | (71.5M) | (86.1M) | (95.5M) |
| EPS | (2.5) | (1.0) | (1.4) |